DarioHealth

DRIO · NASDAQ

$4.08−$0.41 (−9.13%)TodayMarket closed ·
Prev close $4.49

Latest news

  • Press releasePRNewswire

    DarioHealth Announces Independent Aon Analysis that Supports Estimated 2.5%-7.2% In-Year Reduction in Total Healthcare Costs

  • Press releasePRNewswire

    Dario Wins Contract with One of New Jersey's Largest Health Plans Representing 1.5 Million Covered Lives

  • Press releasePRNewswire

    DarioHealth Reports Second Quarter 2026 Financial Results

  • Press releasePRNewswire

    Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand

  • Press releasePRNewswire

    DarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026

  • Press releasePRNewswire

    Dario Launches Integrated GLP-1 Program, Combining Its Digital Chronic Care Platform with Provider-Backed Clinical Care in a Single End-to-End Experience

  • Press releasePRNewswire

    Dario Announces Pricing of a $23.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

  • Press releasePRNewswire

    Fortune 50 Employer Awards Dario Contract to Deliver AI-Powered Cardiometabolic Care Platform

  • Press releasePRNewswire

    Dario Expects Proprietary AI Engine DarioIQ™ to Increase Recurring Revenue from Existing Customers by 10-15%

  • Press releasePRNewswire

    Dario Signs New Agreement with a Major Health Insurer in Arizona Representing Hundreds of Thousands of Lives Through Amwell Partnership

  • Press releasePRNewswire

    Top National Health Plan Extends Agreement for Mental Health and Expands Dario Partnership into Cardiometabolic Care, Demonstrating Successful Multi-Condition Growth Strategy

  • Press releasePRNewswire

    Dario Appoints Former Humana Chief Compliance Officer Sean O'Reilly to Advisory Board to Support Strategic Growth and Healthcare Partnerships

  • Press releasePRNewswire

    Dario Announces Strategic Collaboration with Beluga Health to Deliver Provider-Backed, Integrated Care at Scale

  • Press releasePRNewswire

    Dario Presents Four Studies at American Diabetes Association Scientific Sessions Highlighting Commercial and Clinical Value of its Digital Health Platform

  • Press releasePRNewswire

    Dario More Than Doubles Addressable Market in Solera Health's Network via Expanded Hypertension Program, With Dario Now Reaching Greater Than 500,000 Eligible Lives

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • News

    DarioHealth Reports Q1 2026 Results: Full Earnings Call Transcript

  • News

    Earnings Scheduled For May 13, 2026

  • Press releasePRNewswire

    DarioHealth Reports First Quarter 2026 Financial and Operating Results

  • Press releasePRNewswire

    DarioHealth to Report First Quarter 2026 Results on Wednesday, May 13, 2026

  • Press releasePRNewswire

    Dario Demonstrates Improved Workplace Function and Productivity Outcomes Through Digital Behavioral Health Program: Real-World Study Published in JMIR Formative Research

  • Press releasePRNewswire

    Dario Appoints Veteran Healthcare Executive John R. Palumbo to Board of Directors to Support Accelerated Commercial Scaling

  • News

    Earnings Scheduled For March 19, 2026

  • Press releasePRNewswire

    DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

  • Press releasePRNewswire

    DarioHealth to Report Fourth Quarter and Full Year 2025 Results on Thursday, March 19, 2026

  • Press releasePRNewswire

    Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital Health

  • Press releasePRNewswire

    Dario Uniquely Positioned to Amplify the Impact of Oral GLP-1 Therapies Through Precision Behavioral Support: 79% of Members Already Using Dario's Weight Management

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • Press releasePRNewswire

    Dario Surpasses 100 Scientific Studies, Cementing Leadership Among Digital Health's Most Evidence-Based Platforms

  • Press releasePRNewswire

    Dario Launches DarioIQ™ AI Integration in Dario Health App with Direct-to-Consumer First Version for Hypertension Members

  • News

    Earnings Scheduled For November 13, 2025

  • News

    Examining the Future: DarioHealth's Earnings Outlook

  • NewsAvi Kapoor

    Concentrix Posts Downbeat Earnings, Joins Legacy Education, Kingsoft Cloud And Other Big Stocks Moving Lower In Friday's Pre-Market Session

  • Press releasePRNewswire

    DarioHealth Announces 20-to-1 Reverse Stock Split

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.